These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 24455898)

  • 1. [The phenomenon of release activity and the hypothesis of "spatial" homeostasis].
    Epstein OI
    Usp Fiziol Nauk; 2013; 44(3):54-76. PubMed ID: 24455898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A two-dimensional mathematical model of non-linear dual-sorption of percutaneous drug absorption.
    George K
    Biomed Eng Online; 2005 Jul; 4():40. PubMed ID: 15992411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Principles of pharmacodynamics and their applications in veterinary pharmacology.
    Lees P; Cunningham FM; Elliott J
    J Vet Pharmacol Ther; 2004 Dec; 27(6):397-414. PubMed ID: 15601436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States.
    Stepan AF; Walker DP; Bauman J; Price DA; Baillie TA; Kalgutkar AS; Aleo MD
    Chem Res Toxicol; 2011 Sep; 24(9):1345-410. PubMed ID: 21702456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Strategy of molecular design of drugs: the unification of macro-properties and micro-structures of a molecule].
    Guo ZR
    Yao Xue Xue Bao; 2008 Mar; 43(3):227-33. PubMed ID: 18630256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. General principles of pharmacology.
    Terézhalmy GT; Gagliardi VB
    Dent Clin North Am; 1994 Oct; 38(4):585-601. PubMed ID: 7805936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional view of pharmacology.
    Wainer IW
    Am J Hosp Pharm; 1992 Sep; 49(9 Suppl 1):S4-8. PubMed ID: 1530004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the quality and structural integrity of a complex glycoprotein mixture following extraction from the formulated biopharmaceutical drug product.
    Liu C; Dong S; Xu XJ; Yin Y; Shriver Z; Capila I; Myette J; Venkataraman G
    J Pharm Biomed Anal; 2011 Jan; 54(1):27-36. PubMed ID: 20800406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Modulation of in vivo fate of drugs: fundamental biopharmaceutical and pharmacokinetic aspects].
    Devissaguet JP
    Ann Pharm Fr; 2001 Jul; 59(4):219-26. PubMed ID: 11468575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of kinetic N-order model in description of active substance release from various drug forms. Part 1. Premises and mathematical analysis of the N-order model.
    Marciniak DM; Dryś A; Pluta J; Kubis AA
    Acta Pol Pharm; 2008; 65(1):101-5. PubMed ID: 18536181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug release from liquisolid systems: speed it up, slow it down.
    Nokhodchi A; Hentzschel CM; Leopold CS
    Expert Opin Drug Deliv; 2011 Feb; 8(2):191-205. PubMed ID: 21222556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Liberation of active substance from pharmaceutical suspensions I. Effect of surfactants on the active substance dissolving].
    Maher S; Sipos P; Maher S; Szabóné RP; Eros I
    Acta Pharm Hung; 2007; 77(2):142-9. PubMed ID: 17933274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The strategic use of supramolecular pK(a) shifts to enhance the bioavailability of drugs.
    Ghosh I; Nau WM
    Adv Drug Deliv Rev; 2012 Jun; 64(9):764-83. PubMed ID: 22326487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release-activity: a long way from phenomenon to new drugs.
    Epstein OI
    Bull Exp Biol Med; 2012 Nov; 154(1):54-8. PubMed ID: 23330090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug targeting via retrometabolic approaches.
    Bodor N; Buchwald P
    Pharmacol Ther; 1997; 76(1-3):1-27. PubMed ID: 9535166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic side-effects of common pharmaceuticals: a potential new field in medicine and pharmacology.
    Csoka AB; Szyf M
    Med Hypotheses; 2009 Nov; 73(5):770-80. PubMed ID: 19501473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear quadrupole resonance spectroscopy in studies of biologically active molecular systems--a review.
    Latosińska JN
    J Pharm Biomed Anal; 2005 Jul; 38(4):577-87. PubMed ID: 15908157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure activity relationship in toxicology.
    Vereczkey L
    Acta Physiol Hung; 1995; 83(1):47-50. PubMed ID: 7660836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Strategy of molecular drug design: activity and druggability].
    Guo ZR
    Yao Xue Xue Bao; 2010 May; 45(5):539-47. PubMed ID: 20931752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.